BIMS Summer Research Internship Program Hosts 27 Undergraduates
8/25/2025
UVA's Summer Research Internship Program (SRIP) hosted 27 undergraduate students for a summer research experience in biomedical sciences that concluded on August 1. Selected students from colleges and universities from…
iTHRIV Scholars Program Celebrates Nine Years of Faculty Career Development
8/25/2025
The Integrated Translational Health Research Institute of Virginia (iTHRIV) Scholars Program recently celebrated the start of its ninth year. The all-virtual mentored career development program supports competitively appointed faculty from…
How AI Will Transform Mental Health Support for Breast Cancer Patients
8/25/2025
From virtual counselors that can hear depression creeping into a person’s voice to smart watches that can detect stress, artificial intelligence is poised to revolutionize mental health care for patients…
8/25/2025
The University of Virginia has been awarded a new $3.4 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to tackle one of the most pressing…
Research in Motion: Alison Criss, PhD
8/25/2025
Our research uncovers how the foot soldiers of our immune system, called neutrophils, recognize and respond to microbes, and how pathogens, including the bacterium that causes gonorrhea, manages to subvert…
UVA Researchers Awarded $13 Million to Lead National Study to Battle Leukemia
8/25/2025
UVA Comprehensive Cancer Center Director Thomas P. Loughran Jr., MD, and Professors of Medicine/Hematology and Oncology Charles Chalfant, PhD, and David Feith, PhD, have been awarded a new five-year, $13…
8/20/2025
On the first Thursday of each month, the School of Medicine hosts a seminar highlighting two recently hired assistant professors. Each presenter gives a 30-minute introduction to their research program.…
Date: Sep 4, 2025 - Sep 4, 2025
Start Time: 4:00 pm
End Time: 5:00 pm
New Monoclonal Antibody Targets Deadly Sepsis
8/20/2025
Scientists at the University of Virginia School of Medicine and the University of Michigan have developed a monoclonal antibody to stop sepsis, a deadly full-body infection. The antibody also has…
